Larvol Delta - FORTIFIHN01-A-Study-of-Ficerafusp-Alfa-BCA101-or-Placebo-in-Combination-With-Pembrolizumab-in-FirstLine-PDL1pos-R-or-M-HNSCC

ficerafusp alfa (BCA101) - Bicara Therapeutics

Keytruda (pembrolizumab) - Merck (MSD)

http://clinicaltrials.gov/ct2/show/NCT06788990

Apr 30, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next